Structural and functional changes of the heart in chronic heart failure with preserved left ventricular ejection fraction with excess body weight depending on the presence and form of atrial fibrillation

Authors

DOI:

https://doi.org/10.14739/2310-1210.2021.4.232568

Keywords:

heart remodeling, chronic heart failure, preserved ejection fraction, excess body weight, atrial fibrillation

Abstract

The aim. To examine the features of structural and functional changes of the heart in patients with chronic heart failure with preserved left ventricular ejection fraction (CHF pr EF) with excess body weight depending on the presence and form of atrial fibrillation (AF).

Materials and methods. The study involved 248 patients with CHF pr EF and excess body weight, the mean age was 65.0 ± 11.0 years, 146 females (58.9 %) and 102 males (41.1 %). The first group included 181 patients without concomitant AF, the mean age was 64.0 ± 11.0 years, 110 females (60.8 %) and 71 males (39.2 %); the second group included 67 patients with AF, the mean age was 67.9 ± 11.3 years, 36 females (53.7 %) and 31 males (46.3 %). Subjects with AF were further divided into subgroups: 7 patients with paroxysmal AF, the mean age – 6.7 ± 10.4 years, 3 females (42.9 %) and 4 males (57.1 %), 12 patients with persistent AF, the mean age – 70.8 ± 10.3 years, 10 females (83.3 %) and 2 males (16.7 %); 48 patients with permanent AF, the mean age – 67.3 ± 11.7 years, 23 females (47.9 %) and 25 males (52.1 %).

Results. Patients with concomitant AF had a significantly larger aorta diameter (by 3.0 %), systolic left atrium size (LAs) (by 14.5 %), right atrium size (RA) (by 8.3 %), left ventricle end-diastolic size (LVEDS) (by 7.1 %), left ventricle end-systolic size (LVESS) (by 10.6 %), right ventricle size (RV) (by 13,1 %), mean pulmonary artery pressure (by 20.0 %) and the prevalence of LV eccentric hypertrophy (by 21.0 %; P ˂ 0.001). At the same time, LV wall relative thickness (LV RT) was lower by 6.3 %, LV EF – by 3.4 % and the frequency of LV concentric hypertrophy – by 19.1 % (P ˂ 0.001). In permanent form of AF compared to paroxysmal one, significantly larger LAs (by 10.6 %), RA (by 10.9 %), LV myocardial mass (LV MM) (by 18.1 %) and LV MM index (by 21.1 %) were determined and in contrast to persistent AF, LAs (by 9.8 %), RA (by 11.4 %), LVEDS (by 15.6 %), LVESS (by 15.8 %), RV (by 27, 9 %), LV MM (by 29.8 %), LV MMI (by 14.9 %) were predominant, at the same, LVRT was 12.8 % less.

Conclusions. In patients with CHF pr EF and excess body weight, concomitant AF is associated with greater dilatation of the heart cavities, eccentric hypertrophy predominance, decreased LV contractility and pulmonary hypertension. Compared to other forms, permanent AF is characterized by severe structural and functional changes in the heart, maximal manifestations of LV dilatation and hypertrophy.

Author Biographies

P. P. Bidzilya, Zaporizhzhia State Medical University, Ukraine

MD, PhD, Associate Professor of the Department of Internal Diseases 1 and Simulation Medicine

V. H. Kadzharian, Zaporizhzhia State Medical University, Ukraine

MD, PhD, Associate Professor of the Department of Internal Diseases 1 and Simulation Medicine

References

Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström-Lundqvist, C., Boriani, G., Castella, M., Dan, G. A., Dilaveris, P. E., Fauchier, L., Filippatos, G., Kalman, J. M., La Meir, M., Lane, D. A., Lebeau, J. P., Lettino, M., Lip, G., Pinto, F. J., Thomas, G. N., … ESC Scientific Document Group. (2021). 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. European Heart Journal, 42(5), 373-498. https://doi.org/10.1093/eurheartj/ehaa612

Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J., Coats, A., Falk, V., González-Juanatey, J. R., Harjola, V. P., Jankowska, E. A., Jessup, M., Linde, C., Nihoyannopoulos, P., Parissis, J. T., Pieske, B., Riley, J. P., Rosano, G., Ruilope, L. M., Ruschitzka, F., Rutten, F. H., … ESC Scientific Document Group. (2016). 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal, 37(27), 2129-2200. https://doi.org/10.1093/eurheartj/ehw128

Voronkov, L. H., Amosova, K. M., Dziak, H. V., Zharinov, O. Y., Kovalenko, V. M., Korkushko, O. V., Nesukai, O. H., Sychov, O. S., Rudyk, Yu. S., & Parkhomenko, O. M. (2017). Rekomendatsii Asotsiatsii kardiolohiv Ukrainy z diahnostyky ta likuvannia khronichnoi sertsevoi nedostatnosti (2017) [Guidelines of the Ukrainian Association of Cardiology for the Diagnosis and Treatment of Chronic Heart Failure (2017)]. Sertseva nedostatnist ta komorbidni stany, (1, dodatok 1), 1-66. [in Ukranian].

Vyas, V., Hunter, R. J., Longhi, M. P., & Finlay, M. C. (2020). Inflammation and adiposity: new frontiers in atrial fibrillation. EP Europace, 22(11), 1609-1618. https://doi.org/10.1093/europace/euaa214

Zhou, M., Wang, H., Chen, J., & Zhao, L. (2020). Epicardial adipose tissue and atrial fibrillation: Possible mechanisms, potential therapies, and future directions. Pacing and Clinical Electrophysiology, 43(1), 133-145. https://doi.org/10.1111/pace.13825

Packer, M. (2019). Disease-treatment interactions in the management of patients with obesity and diabetes who have atrial fibrillation: the potential mediating influence of epicardial adipose tissue. Cardiovascular Diabetology, 18(1), Article 121. https://doi.org/10.1186/s12933-019-0927-9

Mahajan, R., Nelson, A., Pathak, R. K., Middeldorp, M. E., Wong, C. X., Twomey, D. J., Carbone, A., Teo, K., Agbaedeng, T., Linz, D., de Groot, J. R., Kalman, J. M., Lau, D. H., & Sanders, P. (2018). Electroanatomical Remodeling of the Atria in Obesity: Impact of Adjacent Epicardial Fat. JACC: Clinical Electrophysiology, 4(12), 1529-1540. https://doi.org/10.1016/j.jacep.2018.08.014

Fenger-Grøn, M., Vinter, N., & Frost, L. (2020). Body mass and atrial fibrillation risk: Status of the epidemiology concerning the influence of fat versus lean body mass. Trends in Cardiovascular Medicine, 30(4), 205-211. https://doi.org/10.1016/j.tcm.2019.05.009

Neefs, J., Boekholdt, S. M., Khaw, K. T., Luben, R., Pfister, R., Wareham, N. J., Meulendijks, E. R., Sanders, P., & de Groot, J. R. (2019). Body mass index and body fat distribution and new-onset atrial fibrillation: Substudy of the European Prospective Investigation into Cancer and Nutrition in Norfolk (EPIC-Norfolk) study. Nutrition, Metabolism & Cardiovascular Diseases, 29(7), 692-700. https://doi.org/10.1016/j.numecd.2019.03.005

Asad, Z., Abbas, M., Javed, I., Korantzopoulos, P., & Stavrakis, S. (2018). Obesity is associated with incident atrial fibrillation independent of gender: A meta-analysis. Journal of Cardiovascular Electrophysiology, 29(5), 725-732. https://doi.org/10.1111/jce.13458

Pan, Y., Xu, L., Yang, X., Chen, M., & Gao, Y. (2021). The common characteristics and mutual effects of heart failure and atrial fibrillation: initiation, progression, and outcome of the two aging-related heart diseases. Heart Failure Reviews. https://doi.org/10.1007/s10741-021-10095-9

Grymonprez, M., Capiau, A., De Backer, T. L., Steurbaut, S., Boussery, K., & Lahousse, L. (2021). The impact of underweight and obesity on outcomes in anticoagulated patients with atrial fibrillation: A systematic review and meta-analysis on the obesity paradox. Clinical Cardiology, 44(5), 599-608. https://doi.org/10.1002/clc.23593

(2020). Correction to: Outcomes of Atrial Fibrillation Ablation in Morbidly Obese Patients Following Bariatric Surgery Compared With a Nonobese Cohort. Circulation: Arrhythmia and Electrophysiology, 13(2), Article e000047. https://doi.org/10.1161/HAE.0000000000000047

Baek, Y. S., Yang, P. S., Kim, T. H., Uhm, J. S., Park, J., Pak, H. N., Lee, M. H., & Joung, B. (2017). Associations of Abdominal Obesity and New-Onset Atrial Fibrillation in the General Population. Journal of the American Heart Association, 6(6), Article e004705. https://doi.org/10.1161/JAHA.116.004705

Santhanakrishnan, R., Wang, N., Larson, M. G., Magnani, J. W., McManus, D. D., Lubitz, S. A., Ellinor, P. T., Cheng, S., Vasan, R. S., Lee, D. S., Wang, T. J., Levy, D., Benjamin, E. J., & Ho, J. E. (2016). Atrial Fibrillation Begets Heart Failure and Vice Versa: Temporal Associations and Differences in Preserved Versus Reduced Ejection Fraction. Circulation, 133(5), 484-492. https://doi.org/10.1161/CIRCULATIONAHA.115.018614

Dong, Z., Du, X., Lu, S., Jiang, C., Xia, S., He, L., Su, X., Jia, Z., Long, D., Sang, C., Tang, R., Liu, N., Bai, R., Yu, R., Dong, J., & Ma, C. (2021). Incidence and predictors of hospitalization in patients with atrial fibrillation: results from the Chinese atrial fibrillation registry study. BMC Cardiovascular Disorders, 21(1), Article 146. https://doi.org/10.1186/s12872-021-01951-5

Yazaki, K., Ejima, K., Kataoka, S., Higuchi, S., Kanai, M., Yagishita, D., Shoda, M., & Hagiwara, N. (2020). Prognostic Significance of Post-Procedural Left Ventricular Ejection Fraction Following Atrial Fibrillation Ablation in Patients With Systolic Dysfunction. Circulation Reports, 2(12), 707-714. https://doi.org/10.1253/circrep.CR-20-0111

Rayner, J. J., Abdesselam, I., d'Arcy, J., Myerson, S. G., Neubauer, S., Watkins, H., Ferreira, V. M., & Rider, O. J. (2020). Obesity-related ventricular remodelling is exacerbated in dilated and hypertrophic cardiomyopathy. Cardiovascular Diagnosis & Therapy, 10(3), 559-567. https://doi.org/10.21037/cdt-19-587

Published

2021-07-01

How to Cite

1.
Bidzilya PP, Kadzharian VH. Structural and functional changes of the heart in chronic heart failure with preserved left ventricular ejection fraction with excess body weight depending on the presence and form of atrial fibrillation. Zaporozhye Medical Journal [Internet]. 2021Jul.1 [cited 2024May20];23(4):469-75. Available from: http://zmj.zsmu.edu.ua/article/view/232568

Issue

Section

Original research